HOME >> MEDICINE >> NEWS
University of Pennsylvania School of Medicine ranked #3 in nation by US News and World Report

Philadelphia, PA The University of Pennsylvania School of Medicine is among the top three research-oriented medical schools in the nation, according to an annual survey of graduate schools by U.S. News and World Report. Penn is ranked #3 in the survey; and is the only medical school in the Delaware Valley to appear in the ranking. The complete survey will be available in the newsstand book, Best Graduate Schools, on April 3rd.

Penn was also ranked in the top ten in four specialty programs including Internal Medicine (#5), Drug/Alcohol Abuse (#6), Women's Health (#4) and Pediatrics (#2). The School of Medicine was also ranked 16th among the top 50 medical schools for students going into primary care.

"Penn's ranking in the survey is representative of the dedication and commitment of our faculty and staff. We are proud to continue our ongoing commitment to national leadership in medical education, patient care and research," said Dr. Arthur Rubenstein, Dean of the University of Pennsylvania's School of Medicine and Executive Vice President of the University of Pennsylvania for the Health System.

The criteria to determine the top research-oriented medical schools included quality assessment, research activity, faculty resources and student selectivity.

According to the survey results, the top three medical schools in rank order are: Harvard University, Johns Hopkins University and the University of Pennsylvania.


'"/>

Contact: Rick Cushman
rick.cushman@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
31-Mar-2006


Page: 1

Related medicine news :

1. Indiana University Imaging Center receives $6M grant for kidney research
2. University hospitals wins multiple national IT awards for electronic patient data bank
3. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
4. University research wins royal accolade
5. New Orleans levee report finished by panel including University of Texas at Austin engineer
6. Boston University School of Medicine faculty member receives honorary degree from alma mater
7. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
8. Emory University researchers find persistent and severe asthma associated with obesity
9. Mid Sweden University leads development of digital color x-rays
10. $2.6M grant awarded to New York University College of Nursing
11. Baby aspirin better for your health, University of Kentucky study says

Post Your Comments:
(Date:8/31/2015)... ... August 31, 2015 , ... ... at Monmouth, was one of the first doctors in the area to perform ... new approach have been impressive: faster recovery, decreased immediate and long-term pain, and ...
(Date:8/31/2015)... ... ... Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved as an ... from Don Bosco Prep in 1990 and was Class Salutatorian. He earned Varsity letters ... senior year. He was inducted into the National Honor Society as a sophomore, was ...
(Date:8/31/2015)... ... 31, 2015 , ... With the FCPX LUT Soft pack from Pixel Film Studios, editors can ... that contains a mathematical formula for modifying an image. The LUT changes every pixel's color ... LUT files. , FCPX LUT Soft requires Final Cut Pro X 10.2 or newer. ...
(Date:8/31/2015)... ... August 31, 2015 , ... How can healthcare meet the ... costs? , In a commentary for The American Journal of Managed Care ... “clinical efficacy,” which would bind parties together in agreements to intervene at the ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... and digital marketing communications company announced today that it has officially launched a ... President, the new website and brand refresh are more closely aligned with the ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3
(Date:8/31/2015)... Aug. 31, 2015  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced that ... Chicago -based Rush University Medical Center ... of escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) ... complete cervical spinal cord injury (SCI). This represents ...
(Date:8/31/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused ... the treatment of diseases of the central nervous system ... submission has passed review by the US Food and ... 1 clinical trial in patients with metastatic colon cancer ... 31 December 2015. Bionomics, CEO & Managing ...
(Date:8/30/2015)... ANDOVER, Massachusetts y LONDRES, August 30, 2015 ... conectada ofrece una visión holística de l ... de todo el trayecto   ... anunciado hoy el debut europeo de IntelliSpace Cardiovascular ... información que ofrece sofisticadas herramientas para acceder, analizar y ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
Cached News: